Ice cream products distributed in retail stores in nine American states have been recalled due to potential Listeria contamination, according to the United States Food and Drug Administration.
The states involved were New York, Massachusetts, Connecticut, Rhode Island, Vermont, Louisiana, Florida, Texas, and New Hampshire.
The recall was initiated by Royal Ice Cream after FDA sampling revealed Listeria monocytogenes' presence on processing equipment. It has expanded its recall to include all products manufactured at the facility within expiry.
Listeria monocytogenes is an organism that can cause serious and sometimes fatal infections in the young, frail or the elderly, and others with weakened immune systems.
Although healthy individuals may only experience short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can also cause miscarriages and stillbirths among pregnant women.
Officials say all affected products will have the manufacturing plant number “CT121” or “CT#121”.
The affected brands were Royal Ice Cream, Batch brand, Ronny Brook Ice cream, New Orleans Ice cream, Maple Valley Ice Cream, Art Cream, Sweet Scoops Yogurt, Gelato Fiasco, Biggy Iggy’s Ice Cream Sandwiches, Munson Chip Wich Ice Cream sandwiches, Giffords Ice cream Sandwiches, Chewy Louie Ice Cream Sandwiches, Snow Wich Ice Cream Sandwich, and Newport Creamery.
So far, no illnesses have been reported related to the product. Those who have purchased the affected products are urged to return them to the place of purchase for a full refund.


White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism
China Eastern Orders 25 Airbus A330neo Jets in $9.35 Billion Deal to Boost International Expansion
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
BOJ Hawk Signals Faster Interest Rate Hikes Amid Inflation Risks
Amazon Prime Day 2026 Sales Top $26.4 Billion as Shoppers Chase Discounts Amid Inflation
Why the future of marijuana legalization remains hazy despite high public support 



